| New insights in mucosal vaccine development V Pavot, N Rochereau, C Genin, B Verrier, S Paul Vaccine 30 (2), 142-154, 2012 | 236 | 2012 |
| Dectin-1 is essential for reverse transcytosis of glycosylated SIgA-antigen complexes by intestinal M cells N Rochereau, D Drocourt, E Perouzel, V Pavot, P Redelinghuys, ... PLoS biology 11 (9), e1001658, 2013 | 187 | 2013 |
| Poly(lactic acid) and poly(lactic-co-glycolic acid) particles as versatile carrier platforms for vaccine delivery V Pavot, M Berthet, J Rességuier, S Legaz, N Handké, SC Gilbert, S Paul, ... Nanomedicine 9 (17), 2703-2718, 2014 | 126 | 2014 |
| Encapsulation of Nod1 and Nod2 receptor ligands into poly (lactic acid) nanoparticles potentiates their immune properties V Pavot, N Rochereau, C Primard, C Genin, E Perouzel, T Lioux, S Paul, ... Journal of controlled release 167 (1), 60-67, 2013 | 101 | 2013 |
| A respiratory syncytial virus (RSV) F protein nanoparticle vaccine focuses antibody responses to a conserved neutralization domain KA Swanson, JN Rainho-Tomko, ZP Williams, L Lanza, M Peredelchuk, ... Science immunology 5 (47), eaba6466, 2020 | 76 | 2020 |
| Cutting edge: New chimeric NOD2/TLR2 adjuvant drastically increases vaccine immunogenicity V Pavot, N Rochereau, J Rességuier, A Gutjahr, C Genin, G Tiraby, ... The Journal of Immunology 193 (12), 5781-5785, 2014 | 74 | 2014 |
| Burden of respiratory syncytial virus infection in community-dwelling older adults in Europe (RESCEU): an international prospective cohort study K Korsten, N Adriaenssens, S Coenen, C Butler, B Ravanfar, H Rutter, ... European Respiratory Journal 57 (4), 2021 | 68 | 2021 |
| Vaccination With Viral Vectors Expressing Chimeric Hemagglutinin, NP and M1 Antigens Protects Ferrets Against Influenza Virus Challenge. KF McMahon M, Asthagiri Arunkumar G, Liu WC, Stadlbauer D, Albrecht RA ... Frontiers in Immunology, 2019 | 54 | 2019 |
| Ebola virus vaccines: Where do we stand? V Pavot Clinical Immunology, 2016 | 51 | 2016 |
| Directing vaccine immune responses to mucosa by nanosized particulate carriers encapsulating NOD ligands V Pavot, N Climent, N Rochereau, F Garcia, C Genin, G Tiraby, ... Biomaterials 75, 327-339, 2016 | 50 | 2016 |
| Preparation and In Vitro Evaluation of Imiquimod Loaded Polylactide-based Micelles as Potential Vaccine Adjuvants G Jiménez-Sánchez, V Pavot, C Chane-Haong, N Handké, C Terrat, ... Pharmaceutical research 32, 311-320, 2015 | 43 | 2015 |
| DNA from KI, WU and Merkel cell polyomaviruses is not detected in childhood central nervous system tumours or neuroblastomas G Giraud, T Ramqvist, DV Pastrana, V Pavot, C Lindau, P Kogner, ... PloS one 4 (12), e8239, 2009 | 42 | 2009 |
| Secretory IgA as a vaccine carrier for delivery of HIV antigen to M cells N Rochereau, V Pavot, B Verrier, A Ensinas, C Genin, B Corthésy, S Paul European journal of immunology 45 (3), 773-779, 2015 | 41 | 2015 |
| Delivery of antigen to nasal-associated lymphoid tissue microfold cells through secretory IgA targeting local dendritic cells confers protective immunity N Rochereau, V Pavot, B Verrier, F Jospin, A Ensinas, C Genin, ... Journal of Allergy and Clinical Immunology 137 (1), 214-222. e2, 2016 | 40 | 2016 |
| Protein-based SARS-CoV-2 spike vaccine booster increases cross-neutralization against SARS-CoV-2 variants of concern in non-human primates V Pavot, C Berry, M Kishko, NG Anosova, D Huang, T Tibbitts, A Raillard, ... Nature communications 13 (1), 1699, 2022 | 37 | 2022 |
| Vaccination with viral vectors expressing NP, M1 and chimeric hemagglutinin induces broad protection against influenza virus challenge in mice. KF Asthagiri Arunkumar G, McMahon M, Pavot V, Aramouni M, Ioannou A, Lambe T ... Vaccine, 2019 | 37 | 2019 |
| Particle-based transcutaneous administration of HIV-1 p24 protein to human skin explants and targeting of epidermal antigen presenting cells F Rancan, S Amselgruber, S Hadam, S Munier, V Pavot, B Verrier, ... Journal of controlled release 176, 115-122, 2014 | 34 | 2014 |
| Loading dendritic cells with PLA-p24 nanoparticles or MVA expressing HIV genes induces HIV-1-specific T cell responses N Climent, S Munier, N Piqué, F García, V Pavot, C Primard, V Casanova, ... Vaccine 32 (47), 6266-6276, 2014 | 26 | 2014 |
| Generation and Production of Modified Vaccinia Virus Ankara (MVA) as a Vaccine Vector V Pavot, S Sebastian, AV Turner, J Matthews, SC Gilbert Recombinant Virus Vaccines: Methods and Protocols, 97-119, 2017 | 20 | 2017 |
| Recent progress in HIV vaccines inducing mucosal immune responses V Pavot, N Rochereau, P Lawrence, MP Girard, C Genin, B Verrier, S Paul Aids 28 (12), 1701-1718, 2014 | 19 | 2014 |
Nicolas RochereauUniversité Jean MonnetVerified email at univ-st-etienne.fr
